Related Experiment Video
Updated: Feb 17, 2026

Quantitative Analysis of Autophagy using Advanced 3D Fluorescence Microscopy
Published on: May 3, 2013
Modulating autophagy in cancer therapy: Advancements and challenges for cancer cell death sensitization
Punya Bhat1, Jurgen Kriel2, Babu Shubha Priya1
1DOS in Chemistry, University of Mysore, Manasgangotri, Mysuru 570006, Karnataka, India.
Abstract:
Autophagy is a major protein degradation pathway capable of upholding cellular metabolism under nutrient limiting conditions, making it a valuable resource to highly proliferating tumour cells. Although the regulatory machinery of the autophagic pathway has been well characterized, accurate modulation of this pathway remains complex in the context of clinical translatability for improved cancer therapies. In particular, the dynamic relationship between the rate of protein degradation through autophagy, i.e. autophagic flux, and the susceptibility of tumours to undergo apoptosis remains largely unclear. Adding to inefficient clinical translation is the lack of measurement techniques that accurately depict autophagic flux. Paradoxically, both increased autophagic flux as well as autophagy inhibition have been shown to sensitize cancer cells to undergo cell death, indicating the highly context dependent nature of this pathway. In this article, we aim to disentangle the role of autophagy modulation in tumour suppression by assessing existing literature in the context of autophagic flux and cellular metabolism at the interface of mitochondrial function. We highlight the urgency to not only assess autophagic flux more accurately, but also to center autophagy manipulation within the unique and inherent metabolic properties of cancer cells. Lastly, we discuss the challenges faced when targeting autophagy in the clinical setting. In doing so, it is hoped that a better understanding of autophagy in cancer therapy is revealed in order to overcome tumour chemoresistance through more controlled autophagy modulation in the future.
Insights
Autophagy, a cellular process, is crucial for cancer cell survival. Understanding its flux is key to developing new cancer therapies that overcome drug resistance.
Area of Science:
- Cell Biology
- Cancer Research
- Metabolism
Background:
- Autophagy is a vital protein degradation pathway supporting cellular metabolism, especially in nutrient-poor conditions, benefiting rapidly growing tumor cells.
- While autophagy's regulation is understood, its precise clinical application in cancer therapy is hindered by complexities.
- The interplay between autophagic flux and tumor apoptosis susceptibility is not fully understood, complicating therapeutic strategies.
Purpose of the Study:
- To clarify autophagy's role in tumor suppression by reviewing literature on autophagic flux and cellular metabolism.
- To emphasize the need for accurate autophagic flux measurement techniques.
- To explore the challenges in clinically targeting autophagy for cancer treatment.
Main Methods:
- Literature review focusing on autophagic flux, cellular metabolism, and mitochondrial function in cancer.
- Analysis of existing studies on the dynamic relationship between autophagy and apoptosis.
- Discussion of clinical translatability and measurement techniques for autophagic flux.
Main Results:
- Autophagic flux and its modulation have context-dependent effects on cancer cell death, with both increased flux and inhibition potentially sensitizing cells.
- Accurate measurement of autophagic flux is a significant barrier to clinical translation.
- The metabolic characteristics of cancer cells are critical for effective autophagy-targeted therapies.
Conclusions:
- Accurate assessment of autophagic flux is essential for effective cancer therapy.
- Targeting autophagy must consider the specific metabolic profile of cancer cells.
- Overcoming tumor chemoresistance may be achieved through controlled autophagy modulation.
More Related Videos
19:44Enhancement of Apoptotic and Autophagic Induction by a Novel Synthetic C-1 Analogue of 7-deoxypancratistatin in Human Breast Adenocarcinoma and Neuroblastoma Cells with Tamoxifen
Published on: May 30, 2012
09:51Author Spotlight: A Selective Luciferase-Based Assay for Monitoring ATG4B 27 Activity in Cells
Published on: June 30, 2023
Related Concept Videos
Autophagic Cell Death
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Autophagy
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...
Targeted Cancer Therapies
There are several types of targeted therapies against...
Delivery Pathways to the Lysosome
Endocytosis
In endocytosis, the cell membrane takes up macromolecules and particles from the surrounding medium. Clathrin-mediated...
The Intrinsic Apoptotic Pathway